2 After you’re diagnosed, your doctor will work with you to make changes to your treatment plan that might include the following 2: Altering your insulin regimen; Making changes to your meal plan; and ...

If a patient has severe hypoglycemia it is mandatory to review dietary practices, insulin injection techniques and timing, and insulin regimen. Exclusion of associated diseases, such as celiac ...

The FDA has granted Orphan Drug designation to ersodetug (RZ358) for the treatment of hypoglycemia due to tumor hyperinsulinism.

Autopsy at the age of six and a half months showed marked islet-cell hyperplasia of the pancreas, suggesting that hyperinsulinism was the immediate cause of the hypoglycemia. Treatment with ACTH ...

In a report released on December 3, Julian Harrison from BTIG maintained a Buy rating on Rezolute (RZLT – Research Report), with a price target ...

MBX 1416 is an investigational long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist in development as a potential treatment for PBH. It was designed using the Company’s novel, proprietary ...

receptor antagonist in development as a potential treatment for PBH. It was designed using the Company’s novel, proprietary PEP™ platform to prevent the occurrence of severe hypoglycemia in ...

Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of ...

In this target trial emulation study, denosumab was found to increase the risk of hypocalcemia requiring emergency treatment as compared with bisphosphonates among women ... Among women who were given ...